Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-001757
Filing Date
2013-04-04
Accepted
2013-04-04 16:52:32
Documents
16
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ebig_fs.htm 10-K 1407150
2 INCENTIVE STOCK PLAN ebig_ex46.htm EX-4.6 191504
3 CONSENT ebig_ex231.htm EX-23.1 2876
4 CERTIFICATION ebig_ex311.htm EX-31.1 18106
5 CERTIFICATION ebig_ex312.htm EX-31.2 18200
6 CERTIFICATION ebig_ex321.htm EX-32.1 9344
7 CERTIFICATION ebig_ex322.htm EX-32.2 9649
8 img001.jpg GRAPHIC 17923
9 img002.jpg GRAPHIC 3758
10 map.jpg GRAPHIC 61968
  Complete submission text file 0001354488-13-001757.txt   3989622

Data Files

Seq Description Document Type Size
11 ebig-20121231.xml EX-101.INS 330027
12 ebig-20121231.xsd EX-101.SCH 28959
13 ebig-20121231_cal.xml EX-101.CAL 34861
14 ebig-20121231_def.xml EX-101.DEF 54425
15 ebig-20121231_lab.xml EX-101.LAB 174905
16 ebig-20121231_pre.xml EX-101.PRE 120054
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 480 966 2020
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52282 | Film No.: 13743555
SIC: 6199 Finance Services